» Articles » PMID: 35304479

Identifying Regions for Enhanced Control of Gambiense Sleeping Sickness in the Democratic Republic of Congo

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Mar 19
PMID 35304479
Authors
Affiliations
Soon will be listed here.
Abstract

Gambiense human African trypanosomiasis (sleeping sickness, gHAT) is a disease targeted for elimination of transmission by 2030. While annual new cases are at a historical minimum, the likelihood of achieving the target is unknown. We utilised modelling to study the impacts of four strategies using currently available interventions, including active and passive screening and vector control, on disease burden and transmission across 168 endemic health zones in the Democratic Republic of the Congo. Median projected years of elimination of transmission show only 98 health zones are on track despite significant reduction in disease burden under medical-only strategies (64 health zones if > 90% certainty required). Blanket coverage with vector control is impractical, but is predicted to reach the target in all heath zones. Utilising projected disease burden under the uniform medical-only strategy, we provide a priority list of health zones for consideration for supplementary vector control alongside medical interventions.

Citing Articles

Understanding Nash epidemics.

Schnyder S, Molina J, Yamamoto R, Turner M Proc Natl Acad Sci U S A. 2025; 122(9):e2409362122.

PMID: 40014574 PMC: 11892628. DOI: 10.1073/pnas.2409362122.


Why the last cases of sleeping sickness will be the hardest to eliminate.

Nuwer R Nature. 2025; .

PMID: 39789138 DOI: 10.1038/d41586-025-00013-6.


Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC.

Davis C, Crump R, Sutherland S, Spencer S, Corbella A, Chansy S PLoS Comput Biol. 2024; 20(4):e1011993.

PMID: 38557869 PMC: 11008881. DOI: 10.1371/journal.pcbi.1011993.


Rational social distancing policy during epidemics with limited healthcare capacity.

Schnyder S, Molina J, Yamamoto R, Turner M PLoS Comput Biol. 2023; 19(10):e1011533.

PMID: 37844111 PMC: 10602387. DOI: 10.1371/journal.pcbi.1011533.


Modelling morbidity for neglected tropical diseases: the long and winding road from cumulative exposure to long-term pathology.

Borlase A, Prada J, Crellen T Philos Trans R Soc Lond B Biol Sci. 2023; 378(1887):20220279.

PMID: 37598702 PMC: 10440174. DOI: 10.1098/rstb.2022.0279.


References
1.
Tirados I, Hope A, Selby R, Mpembele F, Mwamba Miaka E, Boelaert M . Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2020; 14(10):e0008270. PMC: 7608941. DOI: 10.1371/journal.pntd.0008270. View

2.
Kande Betu Ku Mesu V, Kalonji W, Bardonneau C, Valverde Mordt O, Ngolo Tete D, Blesson S . Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health. 2021; 9(7):e999-e1008. PMC: 8220131. DOI: 10.1016/S2214-109X(21)00208-4. View

3.
Capewell P, Atkins K, Weir W, Jamonneau V, Camara M, Clucas C . Resolving the apparent transmission paradox of African sleeping sickness. PLoS Biol. 2019; 17(1):e3000105. PMC: 6345479. DOI: 10.1371/journal.pbio.3000105. View

4.
Arita I, Nakane M, Fenner F . Public health. Is polio eradication realistic?. Science. 2006; 312(5775):852-4. DOI: 10.1126/science.1124959. View

5.
Simarro P, Cecchi G, Paone M, Franco J, Diarra A, Ruiz J . The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr. 2010; 9:57. PMC: 2988709. DOI: 10.1186/1476-072X-9-57. View